# Equivalence of Generic Clozapine to Orally Dissolving Clozapine in Schizophrenia or Schizoaffective Disorder

> **NCT00501618** · PHASE4 · COMPLETED · sponsor: **Manhattan Psychiatric Center** · enrollment: 20 (actual)

## Conditions studied

- Schizophrenia
- Schizoaffective Disorder

## Interventions

- **DRUG:** Fazaclo

## Key facts

- **NCT ID:** NCT00501618
- **Lead sponsor:** Manhattan Psychiatric Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2009-03
- **Final completion:** 2009-07
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2015-04-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00501618

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00501618, "Equivalence of Generic Clozapine to Orally Dissolving Clozapine in Schizophrenia or Schizoaffective Disorder". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00501618. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*